After 12 years’ waiting, the 4th version of the Patent Law with an aim of further motivating innovations and improving the mechanism for cracking down patent infringements was finally passed on October 17, 2020. The amended Chinese patent law will take effect on June 1, 2021. Second Amendments introduced pharmaceutical patent-term extensions and established an early pharmaceutical patent-dispute resolution mechanism and patent linkage system that further protects the rights of patentees.
The European Chamber is delighted to invite Ms Mi LI, Principal at Rouse and the IP Consulting Director of Rouse China in Beijing to break down the changes and challenges, as well as outlooks ahead for our members in the pharmaceutical sector.
Agenda
14:00 – 14:30
|
Registration and networking
|
14:30 – 14:35
|
Welcome remarks by chamber representatives
|
14:35 – 15:15
|
Presentation by Ms Mi LI, Principal, Head of China Patent Team, Rouse
|
15:15 – 15:40
|
Q&A and discussion
|